Showing posts with label Tamiflu. Show all posts
Showing posts with label Tamiflu. Show all posts

Monday, January 28, 2008

Surprising rise in drug resistance in seasonal flu viruses worries experts

From the Canadian Press:
Influenza experts admitted Monday they have been startled by the discovery this season of an unexpectedly high number of human flu viruses that appear to be naturally resistant to Tamiflu, the drug that countries around the world are stockpiling for use in the next flu pandemic.

The viruses have been isolated from people infected with influenza A viruses of the H1N1 subtype in a number of European countries.

Canada's National Microbiology Laboratory in Winnipeg has reported finding one such virus, in a child believed to have caught the flu abroad, and is speeding up testing to see if there are more.

The World Health Organization is convening a virtual meeting of experts Tuesday to try to get a handle on how far afield the resistant virus has been found, how common it is and what the findings signify. ...more

Monday, June 18, 2007

Allocation of antivirals for flu pandemic workers stirs debate

From CBC News:
Public health officials across Canada are grappling with the medical and ethical issues of giving front-line health-care workers preventive antiviral drugs if a flu pandemic strikes.

The federal and provincial governments have stockpiled more than 500 million doses of antiviral drugs to prepare for a pandemic.

Under the current federal plan, the drugs may only be used to treat people once they are ill, a reversal of an original decision two years ago to stockpile antivirals as a preventive treatment or prophylaxis for front-line health-care workers as well. ...more

Wednesday, March 28, 2007

Changes to Canadian labelling of Tamiflu

From Health Canada:
Health Canada wishes to inform Canadians that the Canadian labelling for Tamiflu has recently been updated to include new safety information resulting from adverse reaction reports of abnormal or suicidal behaviour in Japanese children or teenagers taking Tamiflu. As of February 28, 2007, there have been no Canadian reports of deaths or psychiatric adverse events such as abnormal or suicidal behaviour in children or teenagers.

Health Canada has also received preliminary information on eight new cases in Japan of self-harm in patients taking Tamiflu, and is aware that Japan has now restricted use of Tamiflu in patients 10 to 19 years old. Further information is expected from the manufacturer, Hoffman-LaRoche Limited, and appropriate measures will be taken if necessary following analysis. ...more